CW December 2004Issue Number 12 December 2004 ISSN 10593802 Management of Chemotherapy-Induced NeutropeniaThe administration of a new generation of colony-stimulating factor in the early cycle of chemotherapy in breast cancer patients greatly lowers the rate of infection caused by febrile neutropenia.
Go to Previous Page Go to Next Page Source & Additional Reading C. Vogel Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW December 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |